» Articles » PMID: 37936448

Human DNA Mutations and Their Impact on Genetic Disorders

Overview
Specialty Biotechnology
Date 2023 Nov 8
PMID 37936448
Authors
Affiliations
Soon will be listed here.
Abstract

DNA is a remarkably precise medium for copying and storing biological information. It serves as a design for cellular machinery that permits cells, organs, and even whole organisms to work. The fidelity of DNA replication results from the action of hundreds of genes involved in proofreading and damage repair. All human cells can acquire genetic changes in their DNA all over life. Genetic mutations are changes to the DNA sequence that happen during cell division when the cells make copies of themselves. Mutations in the DNA can cause genetic illnesses such as cancer, or they could help humans better adapt to their environment over time. The endogenous reactive metabolites, therapeutic medicines, and an excess of environmental mutagens, such as UV rays all continuously damage DNA, compromising its integrity. One or more chromosomal alterations and point mutations at a single site (monogenic mutation) including deletions, duplications, and inversions illustrate such DNA mutations. Genetic conditions can occur when an altered gene is inherited from parents, which increases the risk of developing that particular condition, or some gene alterations can happen randomly. Moreover, symptoms of genetic conditions depend on which gene has a mutation. There are many different diseases and conditions caused by mutations. Some of the most common genetic conditions are Alzheimer's disease, some cancers, cystic fibrosis, Down syndrome, and sickle cell disease. Interestingly, scientists find that DNA mutations are more common than formerly thought. This review outlines the main DNA mutations that occur along the human genome and their influence on human health. The subject of patents pertaining to DNA mutations and genetic disorders has been brought up.

Citing Articles

Assessing the diagnostic potential of SATB2 and β-catenin as biomarkers and therapeutic targets in pancreatic ductal adenocarcinoma.

Helal N, Maher S, Samir S, Elmeligy H, Aboul-Ezz M, Aboushousha T J Cancer Res Clin Oncol. 2025; 151(2):56.

PMID: 39878802 PMC: 11779791. DOI: 10.1007/s00432-024-06055-z.


DNA Hybridization Kinetics Observed at the Single-Molecule Level Using Graphene Near-Field Effects.

Soares M, Freitas J, Queiros T, Purwidyantri A, Alpuim P, Nieder J J Phys Chem A. 2024; 128(49):10689-10696.

PMID: 39622497 PMC: 11647878. DOI: 10.1021/acs.jpca.4c05740.


Transfer Learning in Cancer Genetics, Mutation Detection, Gene Expression Analysis, and Syndrome Recognition.

Ashayeri H, Sobhi N, Plawiak P, Pedrammehr S, Alizadehsani R, Jafarizadeh A Cancers (Basel). 2024; 16(11).

PMID: 38893257 PMC: 11171544. DOI: 10.3390/cancers16112138.

References
1.
Devine K, Jheeta S . De Novo Nucleic Acids: A Review of Synthetic Alternatives to DNA and RNA That Could Act as Bio-Information Storage Molecules. Life (Basel). 2020; 10(12). PMC: 7764398. DOI: 10.3390/life10120346. View

2.
Hengel S, Spies M, Spies M . Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy. Cell Chem Biol. 2017; 24(9):1101-1119. PMC: 5679738. DOI: 10.1016/j.chembiol.2017.08.027. View

3.
Dodd T, Botto M, Paul F, Fernandez-Leiro R, Lamers M, Ivanov I . Polymerization and editing modes of a high-fidelity DNA polymerase are linked by a well-defined path. Nat Commun. 2020; 11(1):5379. PMC: 7584608. DOI: 10.1038/s41467-020-19165-2. View

4.
Rosendahl Huber A, Van Hoeck A, van Boxtel R . The Mutagenic Impact of Environmental Exposures in Human Cells and Cancer: Imprints Through Time. Front Genet. 2021; 12:760039. PMC: 8565797. DOI: 10.3389/fgene.2021.760039. View

5.
Lyons D, Lauring A . Evidence for the Selective Basis of Transition-to-Transversion Substitution Bias in Two RNA Viruses. Mol Biol Evol. 2017; 34(12):3205-3215. PMC: 5850290. DOI: 10.1093/molbev/msx251. View